Status:
UNKNOWN
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
Lead Sponsor:
University of Leicester
Collaborating Sponsors:
JDRF UK
Conditions:
Type 1 Diabetes
Insulin Pump Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Type 1 diabetes requires people with type 1 diabetes to constantly monitor their blood glucose and adjust their insulin doses to try and keep glucose levels in range. Hybrid closed loop systems (also ...
Detailed Description
Background: Type 1 diabetes (T1D) is a complex lifelong autoimmune condition, characterized by the destruction of the β-cells of the pancreas. There is no cure. Management of type I diabetes mandates...
Eligibility Criteria
Inclusion
- Capacity to provide informed consent
- ≥18 years of age
- Diagnosis of type I diabetes
- Comprehension of English - able to understand study material, participate in the interview and complete the online questionnaires
- On HCL therapy as part of the NHS pilot
Exclusion
- 1\. Diagnosis Type II or other form of diabetes
Key Trial Info
Start Date :
November 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT05348499
Start Date
November 14 2021
End Date
September 1 2023
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leicester Diabetes Research Centre
Leicester, United Kingdom